Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.
Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.
Jun J. Yang, PhD, shares research presented at ASH that highlights the role the GATA3 oncogene plays in a high-risk subset of acute lymphoblastic leukemia.
The annual American Society of Hematology (ASH) meeting offers St. Jude clinicians and researchers the opportunity to learn, network and recruit. Read more.
Learn about new equations to estimate kidney function in young cancer patients more quickly and accurately.
Jun J. Yang, PhD, offers highlights of the first ALL session at the American Society of Hematology (ASH) meeting, including his work on TP53. Read more.
Find out how a researcher applied statistical analysis to chart variance and better understand how childhood leukemia develops.
The Sickle Cell Clinical Research and Intervention Program uses data to determine therapies for children and adults. Learn more.
Find out how poor sleep hampers treatment of young children with cancer
Research shows possible path to restoring critical regions of the brain involved with hearing loss by limiting a neuromodulator in the auditory thalamus.